A moulding device designed to form an implantable provisional joint prosthesis component out of orthopaedic cement (otherwise known as a cement spacer), which is used in two-stage joint revision typically to treat joint arthroplasty infection. It is filled wit
| Company | Devices | Share |
|---|---|---|
| Biomet Orthopedics, Llc | 73 | 51% |
| G21 Srl | 37 | 26% |
| Ortho Development Corporation | 12 | 8% |
| United Orthopedic Corp. | 11 | 8% |
| Berkeley Advanced Biomaterials, Llc | 9 | 6% |
Company = labeler of record on GUDID. 5 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| MBB | BONE CEMENT, ANTIBIOTIC | 63 |
| JWH | PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEM | 46 |
| MBB | Bone Cement, Antibiotic | 37 |
| KWS | Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cement | 30 |
| KWL | Prosthesis, hip, hemi-, femoral, metal | 29 |
| KWY | Prosthesis, hip, hemi-, femoral, metal/polymer, cemented or | 29 |
Use these as the dimensions to specify in a tender line.
142 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Orthopaedic cement spacer mould", from 5 companies. The largest labeler is Biomet Orthopedics, Llc with 51% of records.
MBB (BONE CEMENT, ANTIBIOTIC), JWH (PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEM), MBB (Bone Cement, Antibiotic), KWS (Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cement)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add orthopaedic cement spacer mould to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.